If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.70
Bid: 22.00
Ask: 23.40
Change: 0.00 (0.00%)
Spread: 1.40 (6.364%)
Open: 22.70
High: 22.70
Low: 22.70
Prev. Close: 22.70
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATE AND REVISED OUTLOOK FOR 2023

23 Oct 2023 07:00

RNS Number : 8837Q
Mission Group PLC (The)
23 October 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

23 October 2023

 

THE MISSION GROUP plc

 

("MISSION", "the Group") 

 

TRADING UPDATE AND REVISED OUTLOOK FOR 2023

 

MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, wishes to provide an update on current trading and the Group's outlook for the remainder of the 2023 financial year to 31 December 2023 ("FY2023").

 

At the time of MISSION's interim results announcement on 26 September 2023, the Group stated that:

·

As in previous years, the Group expects the majority of its profit to be generated in the second half of the year.

·

Despite the continued, heightened level of global macro-economic uncertainty, the Group currently remains on track to deliver against the Board's expectations.

 

Trading Update

 

Whilst performance in the first half of 2023 was broadly in line with the Board's expectations and achieved despite considerable industry-wide headwinds, recent trading has rapidly become more challenging than previously anticipated. 

 

This has been especially marked in the Consumer & Lifestyle, Property, and Technology & Mobility business units, where client wins have been more than offset by losses and several clients choosing to defer or significantly reduce spending. The Board now believes these more challenging trading conditions will continue for the remainder of the year and is taking a materially more cautious view on H2 2023 and therefore the FY2023 outturn. 

 

In light of this information, the Board has commenced a detailed operational review including an immediate reassessment of financial expectations and resource allocation. The review will take into account the reduction or rephasing of revenues in the impacted business units, and has begun to identify certain changes to operating costs that will benefit in part FY2023, and FY2024. These initial cost reductions are expected to be fully implemented by year end. In addition, this review is expecting to identify a wider range of efficiencies and business improvements which, over time, should lead to more cost savings. An update on this review will be provided with the FY2023 trading statement early in 2024. 

 

Whilst full year revenue growth is expected to be between 8%-9%, including the impact of 2023 acquisitions, the Board now believes that the outturn for FY2023 will be materially below market expectations (see Note 1). FY2023 headline profits before tax are not expected to be more than £3.1m (see Note 2). This includes costs of £1.2m relating to a business that is expected to be classified as discontinued at year end. Earnings before Interest, Taxation, Depreciation and Amortisation (EBITDA) are expected to be not more than £9.0m on the same basis. 

 

Financial Position

 

As a result of the reduced trading performance, the payment of the final FY2022 dividend, and in particular the rapid reduction in pre-payments from certain clients, the Group's net debt as at 20 October 2023 was approximately £25.5m compared to £14.9m as at 30 June 2023. 

 

The Group's committed bank facilities comprise a revolving credit facility of £20.0m, with an option to increase the facility by £5.0m, which expires on 5 April 2025. Interest on the facility is based on SONIA (sterling overnight index average) plus a margin of between 1.50% and 2.25% depending on the Group's debt leverage ratio, payable in cash on loan rollover dates.

 

In addition to its committed facilities, the Group has available an overdraft facility of up to £6.0m with interest payable by reference to National Westminster Bank plc (Natwest) Base Rate plus 2.25%. Instead of increasing the revolving credit facility by £5.0m, the Group has agreed with Natwest that the overdraft limit of £6.0m will be increased to £10.0m, until further notice and subject to regular review.

 

Net debt is expected to be approximately £24.0m as at 31 December 2023 after a working capital outflow due to the forecast increase in turnover in Q4, resulting in an increase in trade debtors which is not expected to convert into cash until early 2024.

 

The Group continues to be in compliance with its banking covenants but is now expecting the net debt / Adjusted EBITDA covenant in Q4 to be above current covenant limits at 31 December 2023. The Group is in constructive dialogue with Natwest regarding a covenant waiver.

 

The increase in the level of net debt has meant that the interest cost for the year is now expected to be higher than previous forecasts, at approximately £2.40m.

 

Dividend

 

Given the trading outlook and the Group's commitment to reducing its net debt position as soon as possible, the Board has decided that it is in the best interests of shareholders to cancel the interim dividend of 0.87 pence per share (approximately £0.79m) that was due to go ex dividend on 2 November 2023 and be paid to shareholders on 1 December 2023.

 

The Board will review any final FY2023 dividend considering trading conditions and the Group's cash position around the time of its final results release for the period ending 31 December 2023. 

 

Non-Core Disposals

 

The Board has for some months been planning a potential disposal of certain of its non-core businesses as part of MISSION's strategy. These plans are ongoing and may complete in FY2023, but there can be no guarantee that they will progress to a completed transaction.

 

 

 

 

 

 

Outlook

 

The Board is extremely disappointed by the recent adverse change in current trading, and the outlook for the remainder of FY2023.

 

Notwithstanding these short-term trading challenges, the Board believes that MISSION's strategy of deliberate investment in its people and capabilities, when combined with operating cost reductions, leaves the Group well positioned as markets improve. The Board will provide an update on FY2024 prospects in early 2024.

 

Notes:

1. The Group considers market expectations for FY 2023 to be to adjusted profits before tax of £7.9m.

2. Headline results are calculated before start-up costs, acquisition adjustments, goodwill and business impairment and restructuring costs.

 

 

ENQUIRIES

 

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

07730 490384

020 7462 1415

 

Simon Bridges/Andrew Potts/Harry Rees

Canaccord Genuity Limited (Nominated Adviser and Broker)

020 7523 8000

 

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

 

NOTES TO EDITORS

 

MISSION is a collective of digital marketing and communications Agencies employing over 1,000 people across 29 locations and 3 continents. The Group successfully combines its diverse expertise to produce Work That Counts TM for Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real growth for some of the world's biggest brands. www.themission.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMTBPTMTATBRJ
Date   Source Headline
1st Apr 201511:12 amRNSDirector/PDMR Shareholding
30th Mar 20157:00 amRNSDirector/PDMR Shareholding
26th Mar 20157:00 amRNSAudited results for the year to 31 December 2014
3rd Mar 20157:00 amRNSLaunch of bigdog
16th Feb 20157:00 amRNSAcquisition
26th Jan 20157:00 amRNSTrading Update
9th Jan 20157:00 amRNSNotification of Director/PDMR shareholding
7th Jan 20157:00 amRNSIndustry Awards
10th Dec 20149:37 amRNSDirector/PDMR Shareholding
11th Nov 20143:26 pmRNSSIP Announcement
10th Nov 20147:00 amRNSAcquisition
15th Oct 20145:47 pmRNSNotification of Significant Shareholding
10th Oct 201411:49 amRNSHolding(s) in Company
7th Oct 20147:00 amRNSAcquisition & Placing
25th Sep 20147:00 amRNSInterim Results
18th Sep 20147:00 amRNSNotice of Interim Results
4th Aug 20147:00 amRNSAcquisition of Proof Communication Limited
22nd Jul 20143:10 pmRNSAnnual LTIP Awards and Vesting; EBT Share Dealings
14th Jul 20147:00 amRNSTrading Update
26th Jun 201411:30 amRNSDirector/PDMR Shareholding
16th Jun 201412:24 pmRNSResult of AGM
20th May 20147:00 amRNSThe Mission wins gold at 2014 Roses Creative Award
7th May 20147:00 amRNSBray Leino expands Client offering in Singapore
25th Mar 20147:00 amRNSAudited results for the year ended 31 Dec 2013
21st Jan 20147:00 amRNSTrading Update
3rd Jan 20141:25 pmRNSDirector/PDMR Shareholding
29th Nov 20132:59 pmRNSEBT dealing & Exercise of Options
31st Oct 20137:00 amRNSEBT dealing
30th Oct 20137:00 amRNSEBT dealing
23rd Oct 20137:00 amRNSAcquisition of Solaris Healthcare Network Limited
3rd Oct 20134:44 pmRNSDirector Exercise of Options & EBT dealing
19th Sep 20137:00 amRNSInterim results for the six months to 30 June 2013
30th Aug 20137:00 amRNSNotice of Interim Results
19th Jul 20137:00 amRNSDirector Exercise of Options & EBT dealing
17th Jul 20137:00 amRNSDirector Dealing
16th Jul 20137:00 amRNSDirectors' Exercise of Options
12th Jul 20137:00 amRNSDirector/PDMR Shareholding
11th Jul 20134:11 pmRNSAnnual LTIP Awards and Vesting; EBT Share Dealings
11th Jul 20137:00 amRNSDirector/PDMR Shareholding
10th Jul 20137:00 amRNSTrading Update
17th Jun 201312:30 pmRNSResult of AGM
12th Apr 20134:45 pmRNSDirector/PDMR Shareholding
11th Apr 20134:55 pmRNSDirector Dealing
10th Apr 20137:00 amRNSDirector Shareholding
3rd Apr 20137:00 amRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSDirectors' Dealing
27th Mar 20134:10 pmRNSRegistered Office & Availability of Annual Report
25th Mar 20137:00 amRNSFinal Results
22nd Mar 20138:36 amRNSReplacement Notice of Results
22nd Mar 20137:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.